Evogene Ltd. (EVGN)

Evogene Revenue

Evogene had revenue of $9.19M in the twelve months ending March 31, 2024, with 341.99% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $4.19M with 553.67% year-over-year growth. In the year 2023, Evogene had annual revenue of $5.64M with 236.72% growth.

• Revenue (ttm): $9.19M
• Revenue Growth: +341.99%
• P/S Ratio: 3.30
• Revenue / Employee: $64,711
• Employees: 142
• Market Cap: 30.34M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.64M	3.97M	236.72%
Dec 31, 2022	1.68M	745.00K	80.11%
Dec 31, 2021	930.00K	-110.00K	-10.58%
Dec 31, 2020	1.04M	287.00K	38.11%
Dec 31, 2019	753.00K	-994.00K	-56.90%
Dec 31, 2018	1.75M	-1.63M	-48.33%
Dec 31, 2017	3.38M	-3.16M	-48.30%
Dec 31, 2016	6.54M	-4.59M	-41.23%
Dec 31, 2015	11.13M	-3.38M	-23.31%
Dec 31, 2014	14.51M	-3.07M	-17.46%
Dec 31, 2013	17.58M	509.00K	2.98%
Dec 31, 2012	17.07M	2.17M	14.57%
Dec 31, 2011	14.90M	2.34M	18.61%
Dec 31, 2010	12.56M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.